Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• HRS9531 Injection (drug)
• Semaglutide Injection (drug)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• Zhu Xianyi Memorial Hospital,Tianjin Medical University
  Tianjin, Tianjin Municipality, China
  Site recruitment: Not reported

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• GLP-1 agonist (drug)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

The registry does not list facilities in this record. This does not mean the study has no sites.

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• BS-GLP1RA group (combination_product)
• BS group (procedure)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• Xingtai Ninth Hospital
  Xingtai, Hebei, China
  Site recruitment: Recruiting
• Zhengzhou Central Hospita
  Zhengzhou, Henan, China
  Site recruitment: Recruiting
• The Second Affiliated Hospital of Baotou Medical College, Inner Mongolia University of Science and Technology
  Baotou, Inner Mongolia, China
  Site recruitment: Recruiting
• The Second Hospital, Cheeloo College of Medicine, Shandong University
  Jinan, Shandong, China
  Site recruitment: Recruiting
• Sinopharm Tongmei General Hospital
  Datong, Shanxi, China
  Site recruitment: Recruiting
• The First People Hospital Of Yunnan Province
  Kunming, Yunnan, China
  Site recruitment: Recruiting
• China-Japan Friendship Hospital
  Beijing, China
  Site recruitment: Recruiting

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• Semaglutide (drug) — also listed as: Wegovy

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• Seoul National University Hospital
  Seoul, South Korea
  Site recruitment: Recruiting

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• Semaglutide (Ozempic®) (drug)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• Rehman Medical Institute
  Peshawar, Khyber Pakhtunkhwa, Pakistan
  Site recruitment: Not reported

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• Semaglutide (administered by PDS290 pen-injector) (drug)
• Placebo (administered by PDS290 pen-injector) (drug)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• The University of Alabama at Birmingham
  Birmingham, Alabama, United States
  Site recruitment: Not reported
• Washington University School of Medicine
  St Louis, Missouri, United States
  Site recruitment: Not reported

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• Semaglutide 6 mg liquid emulsion formulation (drug)
• Wegovy® (semaglutide) Tablet (drug) — also listed as: Wegovy® (semaglutide) Tablet 25 mg
• Placebo liquid emulsion formulation (drug)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• Clinical Research Institute of Minnesota
  Minneapolis, Minnesota, United States
  Site recruitment: Recruiting

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• Semaglutide Pen Injector [Ozempic] (drug) — also listed as: Ozempic, Wegovy

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• Amish Research Clinic
  Lancaster, Pennsylvania, United States
  Site recruitment: Recruiting

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• Genetic Test (genetic) — also listed as: MyPhenome Test
• Anti-Obesity Medication (AOM) treatment (drug)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

The registry does not list facilities in this record. This does not mean the study has no sites.

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• Semaglutide 2.4 mg (drug)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• Banner MD Anderson Cancer Center at Gateway
  Gilbert, Arizona, United States
  Site recruitment: Not reported

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• SLIMM (behavioral)
• Standard Resistance Training (behavioral)
• Guided Resistance Training (behavioral)
• Placebo (drug)
• Semaglutide (drug)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• Stanford University
  Stanford, California, United States
  Site recruitment: Recruiting
• University of Utah
  Salt Lake City, Utah, United States
  Site recruitment: Recruiting

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• Semaglutide (drug) — also listed as: Rybelsus
• Intranasal insulin (drug) — also listed as: Actrapid
• Semaglutide placebo (other)
• Intranasal insulin placebo (other)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• Joseph Sagol Neuroscience center, Sheba Medical Center
  Ramat Gan, Israel
  Site recruitment: Recruiting

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• Glucagon-Like Peptide-1 Agonist (GLP-1) (drug) — also listed as: GLP-1RA

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• The Ohio State University
  Columbus, Ohio, United States
  Site recruitment: Recruiting

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• Injected GLP-1 Receptor Agonists and Dual Agonists (drug)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• University of Colorado Anschutz School of Medicine
  Aurora, Colorado, United States
  Site recruitment: Recruiting

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• Semaglutide (Wegovy®) (drug)
• ¹⁸FDG-PET/CT with cold stimulation (procedure)
• Liver MRI (PDFF + MRE) (procedure)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• Hallym University Dongtan Sacred Heart Hospital
  Hwaseong-si, Gyeonggi-do, South Korea
  Site recruitment: Not reported
• Seoul National University Bundang Hospital
  Seongnam-si, Gyeonggi-do, South Korea
  Site recruitment: Not reported

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• Unstimulated Whole Saliva Collection (procedure)
• Salivary Analysis (procedure)
• Oral Examination and BEWE Assessment (procedure)
• Standardized Intraoral Photography (procedure)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• Department of Periodontology, Bilecik Seyh Edebali University Faculty of Dentistry
  Bilecik, Merkez, Turkey (Türkiye)
  Site recruitment: Not reported

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• Wegovy (2.4 Mg Dose) + exercise & nutrition (behavioral)
• Wegovy (2.4 Mg Dose) + usual care (other)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• Hadassah Medical Center
  Jerusalem, Israel, Israel
  Site recruitment: Not yet recruiting
• Sheba medical center
  Ramat Gan, Israel, Israel
  Site recruitment: Recruiting

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• Liraglutide (drug)
• Oral Semaglutide (drug)
• Semaglutide (drug)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• Altasciences Clinical LA, Inc.
  Cypress, California, United States
  Site recruitment: Recruiting

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• Metformin (drug)
• semaglutide (drug)
• Anti-hypertensives (drug) — also listed as: The use of angiotensin converting enzyme (ACE) inhibitor or angiotensin receptor blocker (ARB), a calcium channel blocker, or a thiazide diuretic.
• Lipid Lowering Medication (drug) — also listed as: The use of generic statins
• Life style intervention (behavioral)
• Fezolinetant (drug)
• Hormonal therapy (drug)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• University of Colorado-School of Medicine
  Aurora, Colorado, United States
  Site recruitment: Recruiting
• University of North Carolina, School of Medicine
  Chapel Hill, North Carolina, United States
  Site recruitment: Recruiting
• Virginia Commonwealth University
  Richmond, Virginia, United States
  Site recruitment: Recruiting